HDAC4 inhibition has demonstrated significant effects to increase the stability of MAP1S, MAP1S-mediated autophagy flux and degradation of mutant Huntingtin aggregates that are directly impact Huntington's disease [33]. This evidence concerns the gene MAP1S and Huntington disease.